In mice with Tau-ablated AD, a decrease in ROS, a decrease in fission, an increase in fusion, an inhibition of mitochondrial permeability transition pore (mitochondrial permeability transition pore, mPTP) and cyploheximide D, which promotes the normal functioning of mitochondria, and an enhancement of ATP production are observed. The gene discussed is MAPT; the disease is Alzheimer disease.